Marban Linda 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed May 16, 2023
Insider Transaction Report
Form 4
Marban Linda
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-05-12−41,497→ 0 totalExercise: $1.39Exp: 2023-05-14→ Common Stock (0 underlying) - Exercise/Conversion
Common Stock
2023-05-12$1.39/sh+20,749$28,841→ 198,604 total
Footnotes (3)
- [F1]Half of the shares of Common Stock acquired upon exercise of this option were delivered to the Reporting Person's ex-spouse pursuant to a domestic relations order, which transaction is exempt from Section 16 pursuant to Rule 16a-12 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Reporting Person no longer reports as beneficially owned any securities owned by her ex-spouse.
- [F2]This figure reflects the acquisition of 132,060 shares of Common Stock from the Reporting Person's ex-spouse pursuant to a domestic relations order, which acquisition is exempt from Section 16 pursuant to Rule 16a-12 under the Exchange Act. The Reporting Person no longer reports as beneficially owned any securities owned by her ex-spouse.
- [F3]The stock option award is fully vested and exercisable.